US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 18, 2015 (11 years ago)

Milrinone in 0.45% NS

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

What was recalled

Milrinone in 0.45% NS, Packaged as a) 52MG in 65ML Homepumps, b) 80MG in 100ML Homepumps, c) 92MG in 115ML Homepumps, d) 104MG in 130ML Homepumps, e) 112MG in 140ML Homepumps, f) 120MG in 150ML Homepumps, g) 124MG in 155ML Homepumps, h) 128MG in 160ML, i) 136MG in 170ML Homepumps, j) 144MG in 180ML Homepumps, k) 152MG in 190ML Homepumps, l) 160MG in 200ML Homepumps, m) 172MG in 215ML Homepumps, n) 176MG in 220ML Homepumps, and o) 200MG in 250ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.

Recalling firm
Sentara Enterprises
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0616-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Milrinone recalls

See all
Class III · Low risk Terminated

Milrinone Lactate Injection

Reason Failed Impurities/Degradation Specifications

Caplin Steriles Limited NDC 72485-502-01 D-1144-2023
Class II · Moderate risk Terminated

Milrinone

Reason Lack of sterility assurance

Sentara Infusion Services D-0307-2023
Class II · Moderate risk Terminated

Milrinone Lactate Injection 200 mcg

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Pfizer Inc. NDC 0409-2776-23 D-1487-2019
Class II · Moderate risk Terminated

Milrinone Lactate Injection 200 mcg

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Pfizer Inc. NDC 0409-2776-02 D-1486-2019
Class II · Moderate risk Terminated

Milrinone Lactate in 5% Dextrose Injection

Reason Lack of assurance of sterility: customer complaints received for the presence of leaks.

Baxter Healthcare Corporation NDC 0338-6010-48 D-0789-2017